Today, we’d like to introduce our close partner CR2O, a full-service clinical contract research organization (CRO) with extensive experience in managing clinical trials. CR2O provides Triall with in-depth knowledge on all matters related to clinical research. Their clinical research experts support Triall in the design, testing, and validation of our software solutions. Moreover, they provide us with continuous strategic advice and access to a broad network of industry stakeholders. In this article, we explain a bit more about their knowledge, expertise, and network.
Triall aims to address a number of recurring issues and inefficiencies in modern-day clinical research (see this article for more info on the origin of Triall). Our close ties with CR2O have been tremendously helpful in the shaping of our vision as we’ve been able to bounce off ideas as well as test and validate our products with the people that are involved in clinical operations on a daily basis.
A full-service clinical CRO with a footprint in immunology & infectious diseases
CR2O has built extensive experience managing and implementing phase I-IV clinical trials in over 30 countries and accumulated expertise through 100+ clinical trials. While CR2O covers a broad range of therapeutic areas, their primary expertise lies in the immunology & infectious disease domain. In this domain, CR2O has worked together with 75+ study centers across the globe. The team of CR2O is strengthened by world-renowned virologist prof. dr. Ab Osterhaus, who, as CSO of the company, helps design clinical programs geared towards accelerating the development of intervention strategies for human infectious diseases.
‘At CR2O, we have a highly motivated and experienced team that helps our clients navigate the clinical development timeline every step of the way. Our team consists of a variety of highly qualified life-science professionals who undergo rigorous and continuous training throughout their careers at CR2O. Our clients are always our first priority and we guarantee them top quality services. ‘ – Jorden Veeneman PhD (Senior Project Manager)
COVID-19 vaccine clinical trial: Just recently, CR2O announced their involvement in a new COVID-19 clinical trial with DYAI-100 (a C1 produced SARS-CoV-2-S-RBD vaccine candidate), where CR2O will be responsible for managing and supporting clinical and pre-clinical development.
Supported by a global network of leading clinics and research centers
CR2O has a strong network of internationally recognized partners and key opinion leaders. Their network currently spans 5 continents and consists of more than a 100 renowned international research institutes, pharma/biotech companies, and service providers. Their close ties with leading clinics and research centers provides them with access to world-class scientific expertise and subject populations. Their unique combination of scientific expertise, operational efficiency and access to subjects makes them an attractive partner for pharma, biotech and public health organizations.
An invaluable partnership for Triall
CR2O provides Triall with extensive knowledge, hands-on expertise, and a deep network within the clinical trial domain. Their experts are closely involved in the design, testing, and validation of all Triall solutions and have been instrumental in tailoring the functional, non-functional, technical, and UX/UI requirements of our products to the needs of the industry.